Cryptocurrency conferences have continued to take the world by storm, serving as a hub for revolutionary concepts, gathering places for keynote speakers, and entertainment for the general population, with side events featuring the world’s most famous celebrities. With so much attention drawn to these events, many institutions have recognized their influence in not only promoting cryptocurrency itself but also in demonstrating the usefulness of the asset in other industries.
Consider some examples. In the latest 2022 Grammys, the world witnessed a prestigious music awards ceremony that also became the site of thought-provoking discussions about NFTs. Not to mention, the World Economic Forum’s Davos event ended up focusing on the power of blockchain and Web3.0. Taken together, events like this prove that those outside the crypto community care about what blockchain means for their future.
The Longevity Science Foundation is another organization embracing the power of cryptography and discussing it at related events, such as the Aging Research & Drug Discovery (ARDD) conference, to help fund longevity research. The event, which has been running for nine consecutive years, will be held in Copenhagen from August 29 to September 2, where hundreds of in-person attendees and thousands of virtual attendees are expected.
Here, emerging technologies are designed to play a central role in the program while simultaneously representing the ins and outs of the aging process.
Funding scientific breakthroughs
While the ARDD Conference initially grew out of a need to understand the underlying mechanisms of aging, including why humans get disease, age, and why there is no way around it, it has grown into a place to move forward with life. – Change search.
Dr. Morten Shippe Knudsen, one of the event leaders, shares one of these findings, saying:
“One of the big advances in this field is that we can now accurately measure biological aging, what’s called biological clocks. You have people who look younger than they do or who look older than they do. We have different age speeds. We can measure people’s biological speeds by measuring different biomarkers.” …it’s a major breakthrough.”
But, although Scheibye-Knudsen originally focused on the basic science of longevity, he’s no stranger to the role the company has played in getting breakthroughs out of the lab and testing them. Naturally, such progress requires capital, which, by chance, has become a major obstacle to many developments in this field.
However, it won’t be just Big Pharma that will make a difference in funding. It is also the sharing of emerging technologies such as encryption that are aiding this growth. ARDD’s Emerging Technology Workshops will include discussions on new ways to fund research and track progress using decentralized technology. Therefore, as part of the upcoming ARDD conference, participants can expect a focus on medicine, venture capital for investors, and committees on blockchain to be factored into the mix along with the science of longevity.
More information about the Sustainability Science Foundation here
As a result, Scheibye-Knudsen is joined by Alex Zavoronkov, who is the leader of the AI-powered drug discovery company Insilico Medicine and a major shareholder of Longenesis, a company known for using blockchain technology to simplify the sharing of medical data for research and trials. Zhavoronkov then becomes an original perspective for embracing emerging technologies to advance the field of longevity and provide new opportunities for funding.
Bringing communities together
Looking to the future, ARDD will continue to bring people together for productive conversations and advance key breakthroughs. By now, cryptocurrency has already established itself as a significant player in research funding and tracking progress, and that’s just a scratch in the surface.
With the many synergies noted between these two sectors, such as the growing interest in each, attendance at such events is expected to continue to grow, as will the communities around them.